-
Article
Open AccessPerformance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Determining the frequency and distribution of pathogenic germline variants (PGVs) in Austrian prostate cancer (PCa) patients and to assess the accuracy of different clinical risk scores to correctly predict PGVs.
-
Article
Open AccessEvaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis
Squamous cell carcinoma of the penis (PSC) is a rare disease with limited information on the molecular events leading to malignant transformation. In a third of PSC cases, presence of human papilloma virus (HP...
-
Article
Open AccessPrognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration
To investigate the prognostic role of the preoperative systemic immune–inflammation index (SII) in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU).
-
Article
Open AccessVisibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to evaluate whether the addition of dynamic contrast–enhanced i...
-
Article
Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy
To evaluate overactive bladder (OAB) symptoms in patients undergoing diagnostic cystoscopy. Overall changes in the entire study population were assessed, as well as broken down by various subgroups.
-
Article
Open AccessPseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
A small subset of patients treated with immune checkpoint inhibitors manifest atypical patterns of response, the so-called pseudoprogression (PP) and hyperprogression (HP). Their prevalence in urothelial (UC) ...
-
Article
Open AccessPD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients
Until recently, there were no true innovations in the management of locally advanced (aUC) and metastatic urothelial cancer (mUC) in the last three decades. Vinflunine has been approved by the EMA (European Me...
-
Article
Anxiety and depression analyses of patients undergoing diagnostic cystoscopy
To prospectively assess anxiety and depression in patients undergoing diagnostic cystoscopy.
